Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Real Time PCR Assays Compared for Viral Quantification

By LabMedica International staff writers
Posted on 14 Jan 2013
The performance of three real time polymerase chain reaction assays has been compared for the quantification of polyomavirus BK.

Reactivation of latent polyomavirus BK is associated with nephropathy (PVAN) after renal transplantation and the BK viral load determinations are a highly sensitive and specific method for predicting risk for PVAN.

At the Albany Medical Center Hospital (NY, USA) a team of investigators collected 100 anticoagulated plasma specimens from 69 renal transplant patients which were analyzed with three real-time PCR (rt-PCR) assays for BK viral load determination. More...
The rt-PCR assays were evaluated in terms of linearity, dynamic range, and accuracy, against a conventional PCR with primers and probe targeting the large T antigen (TOR) (Integrated DNA Technologies, Coralville, IA, USA).

The two commercial rt-PCR assays used were the MultiCode-RTx BK (MC-RTx) virus Analyte Specific Reagents (ASR) from Luminex (Austin, TX, USA), and the MGB-Alert BKV ASR (MGB) from Epoch Biosciences (Princeton, NJ, USA). A laboratory developed assay (LDA) was also evaluated. Of the 100 specimens from 69 patients sent to the laboratory for routine polyomavirus measurements by the TOR and analyzed with all three rt-PCR assays, 76 were defined as true positive for BKV DNA and no samples were inhibitory for PCR.

The MC-RTx assay was positive for all 76 specimens whereas MGB was positive for 64 and LDA was positive for 55. The viral load range for these samples was from1.71 to 7.55 log10 copies/mL, while the median viral load was 3.01 log10 copies/mL. BKV DNA was not detected by any method in the true negative specimens. The sensitivities of the assays was 100% for MC-RTx, 84% for MGB and 72% for LDA and the specificities were 100% for all three assays.

The authors concluded that all three real-time PCR assays are reliable for measuring BKV loads for the identification of patients at risk for PVAN. These assays demonstrated superiority over the TOR with regards to precision. MC-RTx appears to have enhanced sensitivity and better performance among divergent strains of BK. The study was published on December 27, 2012, in the Journal of Clinical Virology.

Related Links:

Albany Medical Center Hospital
Integrated DNA Technologies
Luminex




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.